Funding Opportunity: The Canadian HIV Technology Development Program


On April 01, 2011, small and medium enterprises (SMEs) in Canada were invited to submit project proposals for the new Canadian HIV Technology Development (CHTD) program.  The CHTD falls under the Translating Basic Science into Clinical Trials program area of the Canadian HIV Vaccine Initiative (CHVI), a collaboration between the Government of Canada and the Bill & Melinda Gates Foundation. 

The new CHTD, a component of the National Research Council’s Industrial Research Assistance Program (NRC-IRAP), aims at advancing the development of a human immunodeficiency virus (HIV) vaccine and related technologies to prevent, diagnose, and treat HIV. 

For more information, please see the attached announcement.
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account